GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

RVSB · Mar 31, 2025

RIVERVIEW BANCORP INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000939057-25-000159Bank
Sequential deposit growth60thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.09% · CORE · VALID

Net-income growth80thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

29.06% · CORE · VALID

Interest-income growth60thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

4.26% · CORE · VALID

Cash and equivalents25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$29.4M · CORE · VALID

Sequential loan growth65thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.68% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History58 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-1.49%
Current
1.09%
Delta
2.59%
Earnings Growth Increased
Previous
-15.15%
Current
29.06%
Delta
44.21%
Interest Income Growth Decreased
Previous
5.99%
Current
4.26%
Delta
-1.73%
Liquidity Increased
Previous
$25.3M
Current
$29.4M
Delta
$4.1M
Loan Growth Increased
Previous
-1.51%
Current
1.68%
Delta
3.19%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.